INTRODUCTION
The most serious complication of maternal genital herpes simplex virus (HSV) infection is neonatal HSV disease, which occurs due to either ascending infection or, more commonly, by delivery through an infected birth canal. 1, 2 The estimated incidence of neonatal HSV infection is approximately one case in 2000 to 5000 deliveries per year. 3 Thus, each year, 1500 to 2000 cases of neonatal herpes infection occur in the United States. 4 The outcome of these infections can be devastating, including death or severe neurodevelopmental disability. 5 Four percent of these cases are acquired prenatally, 86% natally, and 10% postnatally. 2 In the largest case series on intrauterine HSV infections (13 infants), there was clinical evidence of primary genital HSV infection in 4 of the 13 mothers, and only 1 mother had a history compatible with recurrent genital HSV infection during pregnancy. 6 We present a case of fatal neonatal HSV-2 infection in a premature infant delivered by cesarean section to a mother who at delivery had recurrent HSV-2 infection, based on history and maternal antibody titers. It was clinically evident at birth, and subsequently confirmed by laboratory studies, that the infant was infected before delivery, likely from the previous maternal episode during pregnancy. This case illustrates an uncommonly documented, but known complication in a mother with primary disease during pregnancy and recurrent genital herpes at delivery -intrauterine transmission to the fetus.
CASE REPORT
A 27-weeks' gestation male was delivered by caesarean section due to failed tocolysis and deteriorating biophysical profile. Twelve hours before delivery, the mother developed active genital herpes simplex lesions over her labia. The obstetrician reported that her membranes were intact at the time of delivery. The mother had labial lesions 2 months prior (her first known clinical infection), which were culture positive for HSV-2. At that time, a diagnosis of primary genital herpes infection was made by the obstetrician, based on an HSV-2 IgM of 3.5 EIA units (normal <0.9) and HSV-2 IgG of 0.9 EIA units (normal 0.9, Specialty Laboratories, Los Angeles, CA). She did not receive antiviral therapy during her primary infection. She was also noted to have genital condylomata at about 15 weeks' gestation.
At the time of delivery the infant was noted to have multiple vesiculobullous lesions over the entire body ( Figure 1A-C) . His Apgar scores were 7 and 7 at 1 and 5 minutes, respectively. He was immediately intubated, given surfactant, and admitted to the neonatal intensive care unit. Broad-spectrum antibiotics plus acyclovir (10 mg/kg every 8 hours) were administered intravenously. A direct fluorescent antibody (DFA) examination of scrapings from the lesions was positive for HSV-2. An initial chest radiograph showed no infiltrates. Serologic tests for syphilis, HIV, and hepatitis B were negative. Liver enzymes were elevated, with AST of 428 U/l (normal 17 to 59) and ALT of 81 U/l (normal 3 to 45), while total serum bilirubin was 5.1 mg/dl (normal 1.3 to 11.3) on day 3 of life. Subsequently, cultures of the vesicular fluid and blood obtained shortly after birth grew HSV-2. Culture of the amniotic fluid taken at delivery was also positive for HSV-2. Polymerase chain reaction (PCR) on the blood was positive for HSV-2 using the procedure of Kimura et al. 7 A lumbar puncture was not performed
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initially due to the infant's instability, but on day 15 (day 14 of acyclovir), the CSF contained 189 white blood cells (WBCs) /cmm (normal 0 to 5/cmm), with 55% neutrophils, 17% lymphocytes, and 28% monocytes. There were 10,000 red blood cells/cmm (normal 0 to 10/cmm), with 527 mg/dl protein (normal 15 to 45 mg/dl), and 32 mg/dl glucose (normal 60 to 80 mg/dl). Cerebrospinal The placenta was discoid and small, measuring 16.3Â14.7Â1.2 cm, and weighing 229.8 g ( <25th percentile for estimated gestational age). The umbilical cord inserted approximately 2.8 cm from the nearest margin. The fetal surface of the placenta was smooth and had no vesicular lesions. The maternal surface was grossly unremarkable and all cotyledons appeared intact. The umbilical cord was boggy, but no other gross abnormalities were identified. The membranes were somewhat discolored, but not friable or foul smelling.
Microscopic examination of the placenta showed several necrotic abscesses in the intervillous spaces with an intense neutrophilic infiltrate, marked karyorrhexis and degeneration (Figure 2A ). There were varying degrees of neutrophilic infiltration in both intact and degenerating peripheral villi. No intranuclear inclusions were identified in these areas on H&E stain and an immunoperoxidase stain for HSV was negative. Gram stain for bacteria was also negative. Microscopic examination of the membranes showed foci of acute inflammation with frank necrosis in the decidua basalis and chorionic plate ( Figure 2B ). Foci of increased chronic inflammation were also present in these areas, containing a predominantly lymphocytic population. Gram stain was negative in these areas as well. The amnion was not directly involved in the acute or chronic inflammatory process. Small nests of somewhat columnar, more reactive cells were observed, but no intranuclear inclusions or multinucleated giant cells were identified on H&E sections. Immunoperoxidase staining of these reactive cell populations in the amnion was positive for HSV ( Figure 2C ). The child's hospital course was complicated by seizures, bilateral intraventricular hemorrhage (IVH), and sepsis with Candida parapsilosis on day 14 and Klebsiella pneumoniae on day 16. Blood cultures remained positive for both organisms despite adequate antibacterial and antifungal therapy. Due to his severe IVH and progressively deteriorating status, he was taken off life support on day 21, following consultation with the family. An autopsy was requested, but refused by the family.
LITERATURE REVIEW AND DISCUSSION
Genital HSV infection can be acquired primarily or recur during pregnancy. Several studies have suggested associations between HSV infection acquired during pregnancy and preterm labor, intrauterine growth retardation, and spontaneous abortion. 2, 8 Specific maternal IgG against the relevant HSV serotype appears to provide relative protection against intrauterine infection, but this protection is not absolute. Hutto et al. 6 described 13 cases of intrauterine HSV-2 infection, with only 1 of the mothers having recurrent disease.
HSV-2 infects nearly 50% of infants whose mothers have primary genital herpes at delivery, whereas <5% of infants exposed to recurrent maternal infection at the time of delivery become infected. Prober et al. 9 reported no cases of neonatal herpes among 34 exposed babies in mothers with recurrent HSV infection who were shedding virus at the time of delivery. Brown et al. 10 documented infection in 1 of 33 similarly exposed infants. Even with recurrent disease, symptomatic HSV in the mother poses a greater risk than asymptomatic. 11 Other risk factors for acquisition of neonatal HSV infection include: (1) cervical (as opposed to vulvar or buttock) lesions, which result in more virus being shed into vaginal secretions; (2) multiple lesions (greater viral load); (3) high virus inoculum in vaginal secretions, e.g., primary versus recurrent; (4) prolonged rupture of membranes -prolonged exposure to vaginal secretions; and (5) use of fetal scalp electrodes or other instrumentation during delivery -providing a site for viral entry. Our patient's mother apparently suffered a primary HSV-2 infection 2 months before delivery. Her primary lesions had resolved during the interim, but she presented with recurrent new vesicles at the time of delivery. Although it is possible that her primary episode lasted until delivery, it is highly unlikely to have persisted over 2 months and there are no clinical data to support this. At initial diagnosis (week 19 of gestation), her IgM for HSV-2 was 3.6 EIA units (normal <0.9) and the IgG was negative. Eight weeks later at delivery, her IgM was 1.4 EIA units and IgG was 1.1 EIA units (normal 0.9, Specialty Laboratories). The argument could be made that this low IgG with persistently positive IgM is indicative of prolonged primary infection with as yet incomplete seroconversion. However, it should be noted that there are no defined criteria to use serology as the basis for defining prolonged primary infection.
A recent, large, cohort study concluded that HSV infection with seroconversion before labor did not appear to negatively affect the outcome of pregnancy. However, infection acquired near the time of labor was associated with an increased risk for neonatal HSV infection and increased perinatal morbidity. 12 In our case, seroconversion occurred in the mother before delivery, but this did not protect the fetus from infection. Our patient may have been at greater risk for acquisition of HSV due to his prematurity, because the majority of maternal antibody is transferred after 32 weeks of gestation. Also, if HSV ascended into the amniotic fluid before maternal seroconversion, our patient's risk for infection may have increased.
From the clinical appearance of the neonate and the subsequent laboratory studies, it was evident that he had acquired disseminated HSV-2 in utero with possible CNS involvement. The latter could not be determined definitively because the virus was not detected in the CNS by culture or PCR. However, CSF cultures yield virus in only 25% to 40% of all neonatal cases. 11 Also, he had already received 2 weeks of acyclovir therapy before the studies were obtained. Neuroimaging studies may have supported CNS involvement, but could not be performed due to his unstable condition. The IVH, CSF leukocytosis, and elevated protein could be due to HSV infection. 11 Alternatively, the IVH may have been related to prematurity, and the CSF pleocytosis, proteinosis, and hypoglycorrhachia secondary to IVH.
Intrauterine HSV infection can occur as a consequence of either transplacental (rare) or ascending infection. Pathologic examination of the placenta and umbilical cord may provide important clues to the route and/or timing of HSV infection. 13 Although few cases of documented HSV placentitis have been reported, intact fetal membranes at delivery and histopathologic evidence of placentitis would suggest a transplacental route of infection. Conversely, histopathologic evidence of chorioamnionitis indicates ascending infection. In our case, the membranes were intact by gross examination at delivery and there was evidence of placentitis, but there also was histopathologic evidence of chorioamnionitis. The lack of HSV-specific placental cytologic changes and immunostaining suggest ascending infection. Microscopic breaks in the membranes may not have been clinically detected or the membranes may have resealed before delivery. Although amniotic fluid cultures were positive for HSV-2, neither the placenta itself nor the fetal membranes were cultured for HSV. Other potentially useful studies would include PCR on the placenta and amniotic membranes plus umbilical cord sections for histology. Unfortunately, none of these were obtained in our patient.
A question that arises from this case is whether treatment of the primary episode during pregnancy would have helped to reduce the risk of fetal infection by decreasing cervical and vaginal virus titers and perhaps restricting potential access to the amniotic fluid and/or the fetus. Clinicians caring for pregnant women with primary genital HSV infection should consider this option and perhaps offer acyclovir therapy to their patients, after discussing the risks/benefits of such therapy.
CONCLUSION
The clinical and histopathologic evidence in our patient points to a diagnosis of fatal intrauterine transmission of HSV-2 infection in a premature infant born to a mother with primary HSV-2 infection 2 months before delivery and recurrent labial lesions at the time of cesarean delivery. Fetal acquisition clearly occurred before the onset of the mother's recurrence. Amnion invasion probably occurred by the ascending route, although the membranes appeared to be clinically intact at delivery. Clinicians should be alert to the fact that severe invasive HSV disease can occur in infants born to mothers with clinically recurrent disease at delivery.
